本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Madrigal Pharmaceuticals, Inc.

445.85
+10.842.49%
成交量:33.80萬
成交額:1.50億
市值:102.28億
市盈率:-34.70
高:448.13
開:437.20
低:430.00
收:435.01
52周最高:615.00
52周最低:265.00
股本:2,294.00萬
流通股本:1,100.01萬
量比:0.56
換手率:3.07%
股息:- -
股息率:- -
每股收益(TTM):-12.8501
每股收益(LYR):-12.8501
淨資產收益率:-42.49%
總資產收益率:-16.30%
市淨率:16.97
市盈率(LYR):-34.70

資料載入中...

2026/02/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/19

重要事件披露

Form 8-K - Current report
2026/01/30

重要事件披露

Form 8-K - Current report
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]